ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients [7]

J. M. Van Dieren*, A. J. Van Vuuren, J. G. Kusters, E. E.S. Nieuwenhuis, E. J. Kuipers, C. J. Van Der Woude

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

60 Citations (Scopus)
Original languageEnglish
Pages (from-to)1664
Number of pages1
JournalGut
Volume54
Issue number11
Publication statusPublished - Nov 2005
Externally publishedYes

ASJC Scopus Subject Areas

  • Gastroenterology

Cite this